BTIG analyst David Larsen maintains $HealthEquity (HQY.US)$ with a buy rating, and adjusts the target price from $110 to $130.
According to TipRanks data, the analyst has a success rate of 31.5% and a total average return of -9.6% over the past year.
Furthermore, according to the comprehensive report, the opinions of $HealthEquity (HQY.US)$'s main analysts recently are as follows:
HealthEquity is regarded as 'one of the safest companies to own in digital health,' due to the company's robust execution and commanding position within the industry. This perspective is reinforced by a more solid five-year treasury rate.
The firm is citing improving policy fundamentals, better visibility into demand trends, and a robust economy and labor market in updating its model. It adds that as health-tech and services move closer to the consumer with digital products, HealthEquity's incoming CEO will help facilitate growth.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
